National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
MLN518

 A substance being studied in the treatment of some types of cancer. It may stop cancer cell growth by blocking certain enzymes. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called CT53518 and tandutinib.

Previous Definitions:mitoxantrone, mivobulin isethionate, mixed glioma, MK0752, MLN2704
Next Definitions:MLN591DM1, MMMT, modafinil, modality, modified radical mastectomy